OCUL logo

Ocular Therapeutix, Inc. (OCUL)

Profile

Full Name

Ocular Therapeutix, Inc.

Ticker

NASDAQ: OCUL

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

July 25, 2014

Indexes

Not included

Website

https://www.ocutx.com

Employees

274

Key Details

Price

$12.83(-1.69%)

Market cap

$2.23B(Mid cap)

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$63.72M(+9.03% YoY)

Annual EPS

-$1.22(-20.79% YoY)

PE ratio

-

Next earnings date

Nov 10, 2025

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    See Full Chart & Historical Data

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $12.83
    OCUL price is $12.83

    30-Day Relative Volume

    0.66
    OCUL 30-day relative volume is 0.66

    Price Performance

    Price Today change

    -1.69%
    OCUL price is down -1.69% today

    Price YTD change

    +50.23%
    OCUL price is up +50.23% since January 1st

    Price 1-year change

    +52.01%
    OCUL price is up +52.01% year-on-year

    Price 3-year change

    +114.55%
    OCUL price is up +114.55% over the past 3 years

    Price Range

    Price All-time high

    $44.19
    OCUL price is currently -70.97% below its historical high of $44.19

    Price 3-year low

    $2.00
    OCUL price is currently +543.11% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market cap

    $2.23B
    OCUL market capitalization is $2.23 billion

    Market cap 3-year change

    +385.02%
    OCUL market capitalization is up +385.02% over the past 3 years

    Market cap All-time high

    $2.37B
    OCUL market capitalization is currently -5.66% below its historical high of $2.37 billion

    Market cap sector rank

    82.18%
    OCUL market capitalization is higher than 82.18% of companies in Healthcare sector

    Shares Outstanding

    Shares Outstanding 1-Year Change

    +11.59%
    OCUL shares outstanding is up +11.59% year-on-year

    Shares Outstanding 3-Year Change

    +126.06%
    OCUL shares outstanding is up +126.06% over the past 3 years

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    1.40
    OCUL beta is 1.40

    200-day SMA

    $8.95
    OCUL price is currently +43.30% above its 200-day simple moving average

    50-day SMA

    $11.84
    OCUL price is currently +8.41% above its 50-day simple moving average

    RSI

    58.55
    OCUL 14-day relative strength index is 58.55

    Volume

    0.66
    OCUL 30-day relative volume is 0.66

    ATR

    $0.60
    OCUL average true range is $0.60

    10-day Historical Volatility

    59.42%
    OCUL 10-day historical volatility is 59.42%

    Dividend

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    $63.72M
    OCUL annual revenue is $63.72 million

    Revenue Analysts estimate

    $54.69M
    OCUL annual revenue is currently +16.51% higher than the consensus analysts' forecast

    Revenue 1-year change

    +9.03%
    OCUL annual revenue is up +9.03% year-on-year

    Revenue Sector rank

    63.95%
    OCUL annual revenue is higher than 63.95% of companies in Healthcare sector

    EPS

    EPS

    -$1.22
    OCUL annual earnings per share is -$1.22

    EPS Analysts estimate

    -$1.49
    OCUL annual earnings per share is currently -18.26% lower than the consensus analysts' forecast

    EPS 1-year change

    -20.79%
    OCUL annual earnings per share is down -20.79% year-on-year

    EPS Sector rank

    47.52%
    OCUL annual earnings per share is higher than 47.52% of companies in Healthcare sector

    Profit

    Gross profit

    $58.10M
    OCUL annual gross profit is $58.10 million

    Gross margin

    91.17%
    OCUL annual gross profit margin is 91.17%

    Operating profit

    -$171.78M
    OCUL annual operating income is -$171.78 million

    Operating margin

    -269.57%
    OCUL annual operating profit margin is -269.57%

    Net income

    -$193.51M
    OCUL annual net profit is -$193.51 million

    Net margin

    -303.67%
    OCUL annual net profit margin is -303.67%

    Expenses

    Total expenses

    $235.50M
    OCUL annual total expenses is $235.50 million

    Operating expenses

    $229.88M
    OCUL annual total operating expenses is $229.88 million

    Cost of goods sold

    $5.63M
    OCUL annual cost of goods sold is $5.63 million

    Selling, general & administrative expenses

    $102.24M
    OCUL annual SGA is $102.24 million

    Depreciation and amortization

    $3.79M
    OCUL annual depreciation & amortization is $3.79 million

    Interest expense

    $13.58M
    OCUL annual interest expense is $13.58 million

    Income tax

    $0.00
    OCUL annual income tax is $0.00

    EBIT & EBITDA

    EBIT

    -$179.93M
    OCUL annual earnings before interest & taxes is -$179.93 million

    EBITDA

    -$176.14M
    OCUL annual EBITDA is -$176.14 million

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total assets

    $457.94M
    OCUL annual total assets is $457.94 million

    Non current assets

    $16.95M
    OCUL annual long term assets is $16.95 million

    Current assets

    $440.99M
    OCUL annual total current assets is $440.99 million

    Cash and cash equivalents

    $392.10M
    OCUL annual cash & cash equivalents is $392.10 million

    Accounts receivable

    $32.39M
    OCUL annual accounts receivable is $32.39 million

    Inventory

    $3.04M
    OCUL annual inventory is $3.04 million

    Liabilities

    Total liabilities

    $142.59M
    OCUL annual total liabilities is $142.59 million

    Long term liabilities

    $101.24M
    OCUL annual total long term liabilities is $101.24 million

    Current liabilities

    $41.35M
    OCUL annual total current liabilities is $41.35 million

    Accounts payable

    $4.18M
    OCUL annual accounts payable is $4.18 million

    Debt

    Total debt

    $75.78M
    OCUL annual total debt is $75.78 million

    Total debt 1-year change

    -9.12%
    OCUL annual total debt is down -9.12% year-on-year

    Long term debt

    $73.85M
    OCUL annual long term debt is $73.85 million

    Short term debt

    $1.93M
    OCUL annual short term debt is $1.93 million

    Equity & Capital

    Shareholders equity

    $315.34M
    OCUL annual stockholders equity is $315.34 million

    Book value

    $315.34M
    OCUL annual book value is $315.34 million

    Retained earnings

    -$891.08M
    OCUL annual retained earnings is -$891.08 million

    Working capital

    $399.63M
    OCUL annual working capital is $399.63 million

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash from operations

    -$134.68M
    OCUL annual cash flow from operations is -$134.68 million

    Cash from operations 1-year change

    -91.75%
    OCUL annual cash flow from operations is down -91.75% year-on-year

    Cash from investing

    -$1.29M
    OCUL annual cash flow from investing activities is -$1.29 million

    Cash from investing 1-year change

    +78.84%
    OCUL annual cash flow from investing activities is up +78.84% year-on-year

    Cash from financing

    $332.11M
    OCUL annual cash flow from financing activities is $332.11 million

    Cash from financing 1-year change

    +95.56%
    OCUL annual cash flow from financing activities is up +95.56% year-on-year

    CAPEX

    CAPEX

    $1.29M
    OCUL annual capital expenditures is $1.29 million

    CAPEX 1-year change

    -78.84%
    OCUL annual capital expenditures is down -78.84% year-on-year

    Free Cash Flow

    Free cash flow

    -$135.97M
    OCUL annual free cash flow is -$135.97 million

    Free cash flow 1-year change

    -78.15%
    OCUL annual free cash flow is down -78.15% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross margin

    91.17%
    OCUL annual gross profit margin is 91.17%

    Operating margin

    -269.57%
    OCUL annual operating profit margin is -269.57%

    Net margin

    -303.67%
    OCUL annual net profit margin is -303.67%

    ROA & ROE

    ROA

    -54.51%
    OCUL annual return on assets is -54.51%

    ROE

    -95.21%
    OCUL annual return on equity is -95.21%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE ratio

    -
    OCUL price to earnings ratio value is unknown

    PE ratio Sector rank

    -
    OCUL price to earnings ratio is unknown

    PB Ratio

    PB ratio

    7.30
    OCUL price to book ratio is 7.30

    PB ratio Sector rank

    84.67%
    OCUL price to book ratio is higher than 84.67% of companies in Healthcare sector

    PS Ratio

    PS ratio

    39.40
    OCUL price to sales ratio is 39.40

    PS ratio Sector rank

    85.11%
    OCUL price to sales ratio is higher than 85.11% of companies in Healthcare sector

    Enterprise value

    Enterprise value

    $1.92B
    OCUL enterprise value is $1.92 billion

    Enterprise value Sector rank

    79.8%
    OCUL enterprise value is higher than 79.8% of companies in Healthcare sector

    EV/EBITDA

    EV/EBITDA

    -9.57
    OCUL EV/EBITDA is -9.57

    EV/EBITDA Sector rank

    13.97%
    OCUL EV/EBITDA is higher than 13.97% of companies in Healthcare sector

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current ratio

    10.66
    OCUL annual current ratio is 10.66

    Quick ratio

    10.59
    OCUL annual quick ratio is 10.59

    Leverage

    Debt to equity

    0.22
    OCUL annual debt to equity ratio is 0.22

    Interest coverage ratio

    -13.25
    OCUL annual interest coverage ratio is -13.25

    Risk & Stability

    Piotroski F-Score

    1
    OCUL piotroski f-score is 1

    Altman Z-Score

    6.56
    OCUL altman z-score is 6.56

    Analyst ratings

    Recent major analysts updates

    Aug 6, 25 Scotiabank
    Sector Outperform
    Aug 5, 25 Needham
    Buy
    May 29, 25 HC Wainwright & Co.
    Buy
    May 6, 25 Needham
    Buy
    Apr 8, 25 William Blair
    Outperform
    Apr 8, 25 Needham
    Buy
    Mar 18, 25 RBC Capital
    Outperform
    Mar 11, 25 Needham
    Buy
    Mar 4, 25 HC Wainwright & Co.
    Buy
    Mar 4, 25 Citizens Capital Markets
    Market Outperform

    Institutional Ownership

    Screeners with OCUL included

    Growing Shares Outstanding
    Mid cap stocks
    US stocks
    Stocks with high beta
    Most recommended stocks
    Best performing stocks last 3 months
    Best performing stocks last 5 years
    NASDAQ Dividend Calendar
    Stocks above SMA 50
    Stocks below analysts price target
    • What is the ticker symbol for Ocular Therapeutix, Inc.?
    • Does Ocular Therapeutix, Inc. pay dividends?
    • What sector is Ocular Therapeutix, Inc. in?
    • What industry is Ocular Therapeutix, Inc. in?
    • What country is Ocular Therapeutix, Inc. based in?
    • When did Ocular Therapeutix, Inc. go public?
    • Is Ocular Therapeutix, Inc. in the S&P 500?
    • Is Ocular Therapeutix, Inc. in the NASDAQ 100?
    • Is Ocular Therapeutix, Inc. in the Dow Jones?
    • When was Ocular Therapeutix, Inc.'s last earnings report?
    • When does Ocular Therapeutix, Inc. report earnings?

    What is the ticker symbol for Ocular Therapeutix, Inc.?

    The ticker symbol for Ocular Therapeutix, Inc. is NASDAQ:OCUL

    Does Ocular Therapeutix, Inc. pay dividends?

    No, Ocular Therapeutix, Inc. does not pay dividends

    What sector is Ocular Therapeutix, Inc. in?

    Ocular Therapeutix, Inc. is in the Healthcare sector

    What industry is Ocular Therapeutix, Inc. in?

    Ocular Therapeutix, Inc. is in the Biotechnology industry

    What country is Ocular Therapeutix, Inc. based in?

    Ocular Therapeutix, Inc. is headquartered in United States

    When did Ocular Therapeutix, Inc. go public?

    Ocular Therapeutix, Inc.'s initial public offering (IPO) was on July 25, 2014

    Is Ocular Therapeutix, Inc. in the S&P 500?

    No, Ocular Therapeutix, Inc. is not included in the S&P 500 index

    Is Ocular Therapeutix, Inc. in the NASDAQ 100?

    No, Ocular Therapeutix, Inc. is not included in the NASDAQ 100 index

    Is Ocular Therapeutix, Inc. in the Dow Jones?

    No, Ocular Therapeutix, Inc. is not included in the Dow Jones index

    When was Ocular Therapeutix, Inc.'s last earnings report?

    Ocular Therapeutix, Inc.'s most recent earnings report was on August 5, 2025

    When does Ocular Therapeutix, Inc. report earnings?

    The next expected earnings date for Ocular Therapeutix, Inc. is November 10, 2025
    On this page